Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.49)
# 314
Out of 4,711 analysts
117
Total ratings
45.19%
Success rate
37.34%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGTX Cognition Therapeutics | Upgrades: Buy | $1 → $1.5 | $0.63 | +138.06% | 3 | Dec 19, 2024 | |
| VKTX Viking Therapeutics | Initiates: Buy | $109 | $42.25 | +157.99% | 1 | Nov 22, 2024 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Neutral | $194 → $236 | $308.44 | -23.49% | 11 | Nov 5, 2024 | |
| NVAX Novavax | Reiterates: Buy | $23 → $26 | $8.70 | +198.85% | 19 | Oct 10, 2024 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $6 | $4.05 | +48.15% | 2 | Oct 7, 2024 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | $33 | $17.16 | +92.31% | 1 | Sep 19, 2024 | |
| HROW Harrow | Reiterates: Buy | $50 | $34.22 | +46.11% | 1 | Aug 29, 2024 | |
| ALT Altimmune | Reiterates: Buy | $20 | $8.25 | +142.42% | 9 | Aug 12, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $55 | $19.45 | +182.78% | 6 | Aug 12, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $29 → $34 | $32.20 | +5.59% | 13 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 → $5 | $3.18 | +57.23% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $92 | $48.87 | +88.25% | 3 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 | $0.62 | +222.79% | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $3.75 | +6.67% | 3 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.45 | +793.85% | 1 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $21.45 | +77.16% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.61 | +390.76% | 5 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $2.83 | +5,553.71% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $5 | $1.56 | +220.51% | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $44 | $2.35 | +1,772.34% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $90 | $1.72 | +5,132.56% | 4 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.56 | +616.85% | 1 | Jun 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $7 | $4.40 | +59.09% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $90 | $0.17 | +53,535.28% | 3 | Jan 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $270 | $1.90 | +14,110.53% | 2 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $138 → $77 | $15.48 | +397.42% | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1,980 → $1,440 | $3.05 | +47,113.11% | 3 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.04 | +284.62% | 2 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $39 | $94.23 | -58.61% | 2 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $11 | $2.17 | +406.91% | 1 | Mar 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $34 | $3.80 | +794.74% | 1 | Mar 13, 2020 |
Cognition Therapeutics
Dec 19, 2024
Upgrades: Buy
Price Target: $1 → $1.5
Current: $0.63
Upside: +138.06%
Viking Therapeutics
Nov 22, 2024
Initiates: Buy
Price Target: $109
Current: $42.25
Upside: +157.99%
Madrigal Pharmaceuticals
Nov 5, 2024
Maintains: Neutral
Price Target: $194 → $236
Current: $308.44
Upside: -23.49%
Novavax
Oct 10, 2024
Reiterates: Buy
Price Target: $23 → $26
Current: $8.70
Upside: +198.85%
Trevi Therapeutics
Oct 7, 2024
Reiterates: Buy
Price Target: $6
Current: $4.05
Upside: +48.15%
Centessa Pharmaceuticals
Sep 19, 2024
Initiates: Buy
Price Target: $33
Current: $17.16
Upside: +92.31%
Harrow
Aug 29, 2024
Reiterates: Buy
Price Target: $50
Current: $34.22
Upside: +46.11%
Altimmune
Aug 12, 2024
Reiterates: Buy
Price Target: $20
Current: $8.25
Upside: +142.42%
Arrowhead Pharmaceuticals
Aug 12, 2024
Reiterates: Buy
Price Target: $55
Current: $19.45
Upside: +182.78%
TG Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $32.20
Upside: +5.59%
Jul 31, 2024
Downgrades: Neutral
Price Target: $18 → $5
Current: $3.18
Upside: +57.23%
Jun 4, 2024
Maintains: Buy
Price Target: $122 → $92
Current: $48.87
Upside: +88.25%
Jan 31, 2024
Upgrades: Buy
Price Target: $2
Current: $0.62
Upside: +222.79%
Dec 20, 2023
Maintains: Buy
Price Target: $8 → $4
Current: $3.75
Upside: +6.67%
Oct 13, 2023
Initiates: Buy
Price Target: $4
Current: $0.45
Upside: +793.85%
Sep 6, 2023
Initiates: Buy
Price Target: $38
Current: $21.45
Upside: +77.16%
Apr 10, 2023
Maintains: Buy
Price Target: $7 → $3
Current: $0.61
Upside: +390.76%
Mar 29, 2023
Reiterates: Buy
Price Target: $160
Current: $2.83
Upside: +5,553.71%
Aug 19, 2022
Downgrades: Neutral
Price Target: $11 → $5
Current: $1.56
Upside: +220.51%
Aug 11, 2022
Maintains: Buy
Price Target: $58 → $44
Current: $2.35
Upside: +1,772.34%
Jul 14, 2022
Maintains: Buy
Price Target: $120 → $90
Current: $1.72
Upside: +5,132.56%
Jun 14, 2022
Initiates: Buy
Price Target: $4
Current: $0.56
Upside: +616.85%
May 24, 2022
Downgrades: Neutral
Price Target: $14 → $7
Current: $4.40
Upside: +59.09%
Jan 24, 2022
Maintains: Buy
Price Target: $195 → $90
Current: $0.17
Upside: +53,535.28%
Nov 30, 2021
Maintains: Buy
Price Target: $500 → $270
Current: $1.90
Upside: +14,110.53%
Jan 15, 2021
Downgrades: Neutral
Price Target: $138 → $77
Current: $15.48
Upside: +397.42%
May 22, 2020
Downgrades: Neutral
Price Target: $1,980 → $1,440
Current: $3.05
Upside: +47,113.11%
Apr 3, 2020
Maintains: Buy
Price Target: $8 → $4
Current: $1.04
Upside: +284.62%
Mar 18, 2020
Maintains: Buy
Price Target: $47 → $39
Current: $94.23
Upside: -58.61%
Mar 13, 2020
Maintains: Buy
Price Target: $22 → $11
Current: $2.17
Upside: +406.91%
Mar 13, 2020
Maintains: Buy
Price Target: $43 → $34
Current: $3.80
Upside: +794.74%